The development of imatinib as a therapeutic agent for sorted by
relevance

Admin01.09.2021

The development of imatinib as a therapeutic agent for

83010
Admin21.07.2021

(PDF) Development of peptide inhibitor as a therapeutic

7803
Admin14.09.2021

(PDF) Cardiotoxicity of the cancer therapeutic agent

5900
Admin01.10.2021

The development of imatinib as a therapeutic agent for

5901
Admin13.08.2021

The development of imatinib as a therapeutic agent for

9605
Admin20.08.2021

In reply to Cardiotoxicity of the cancer therapeutic

3400
Admin14.09.2021

The development of imatinib as a therapeutic agent for

Admin14.07.2021

(PDF) Endometrial Cancer: Molecular and Cellular Basis of

5901
Admin06.10.2021

(PDF) Clinical relevance of vascular endothelial growth

1502
Admin10.08.2021

(PDF) Expression differences of miR-142-5p between

3002
Admin17.09.2021

The development of imatinib as a therapeutic agent for

9709
Admin10.08.2021

The development of imatinib as a therapeutic agent for

9202
Admin07.09.2021

$1.5M NIH Grant Supports Development of Therapeutic Agent

7709
Admin05.10.2021

[Full text] Resistant mutations in CML and Ph+ALL - role

8805
Admin07.10.2021

PPT - Development of Therapeutic Agents Based on the GLP-1

74010
Admin09.08.2021

Imatinib resistance in chronic myeloid leukaemia caused by

9506
Admin16.08.2021

High-sensitivity detection of BCR-ABL kinase domain

7208
Admin20.08.2021

Cardiotoxicity of the cancer therapeutic agent imatinib

7804
Admin23.07.2021

(PDF) Potential opportunity in the development of new

8302
Admin16.09.2021

5MJCB4-TKI

2702
Admin19.07.2021

IMATINIB Synthesis, SAR, MCQ,Structure,Chemical Properties

8303